Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Scientists discover new molecular drivers of Parkinson's disease

Scientists at the Icahn School of Medicine at Mount Sinai have uncovered new molecular drivers of Parkinson's disease using a sophisticated statistical technique called multiscale gene network analysis.

20 Nov 2019

Researchers develop new technology to inhibit the development of Alzheimer's disease

Researchers at the Technion-Israel Institute of Technology and their partners at Bar Ilan University have developed new technology to inhibit the development of Alzheimer's disease.

18 Nov 2019

High-fat maternal diet can cause life-long changes in the fetal brain

A study team at MedUni Vienna’s Center for Brain Research has found that high-fat maternal diets can cause life-long changes in the brain of the unborn offspring.

18 Nov 2019

Study: Almost 10% of diverse Latino populations meet the criteria for mild cognitive impairment

A study of over 6,300 Latinos of Dominican, Central American, Cuban, Mexican Puerto Rican and South American heritage estimates that nearly 10% of middle-age and older Latinos in the U.S. meet the criteria for mild cognitive impairment.

18 Nov 2019

Key Alzheimer's gene variants act differently among Caribbean Hispanics based on ancestry

Researchers looking to uncover the mysteries of Alzheimer's disease have revealed new insights from old variants.

15 Nov 2019

Study: Many patients treated for iNPH also develop Alzheimer’s disease

Up to one in five patients treated for idiopathic normal pressure hydrocephalus, iNPH, also develop Alzheimer’s disease, according to a new study from the University of Eastern Finland and Kuopio University Hospital.

15 Nov 2019

Non-coding enhancer DNA may be key for identifying genetic risk in neurological conditions

One might think that the primary cause of most genetically linked diseases comes from mutations in coding DNA -- alterations in coding regions of the genome that can lead directly to changes in the expression of particular proteins important for a healthy body.

14 Nov 2019

Alzheimer's Association's funding enables expansion of aging study in longest running birth cohort

The Alzheimer's Association and University College London are partnering to study brain aging and dementia in 500 individuals whose health and health-related behaviors have been documented since birth.

14 Nov 2019

Good fitness linked to longer life without dementia

It is important to say that it is never too late to begin exercising. The average participant in our study was around 60 years old at baseline, and improvement in cardiorespiratory fitness was strongly linked to lower dementia risk.

14 Nov 2019

Alzheimer's Research UK urges all political parties to invest in dementia research

Alzheimer's Research UK is calling on all political parties to drive forward efforts to find life-changing treatments for dementia – by urging them to commit just 1% of the annual cost of dementia on research in this general election.

14 Nov 2019

People who are illiterate may have greater risk of developing dementia

New research has found that people who are illiterate, meaning they never learned to read or write, may have nearly three times greater risk of developing dementia than people who can read and write.

13 Nov 2019

Regular co-use of pain and sleep medications may increase risk of frailty in older adults

Researchers from the Oregon Research Institute and Florida Atlantic University are the first to demonstrate statistically significant links between self-reported regular use of prescription drugs for pain and/or sleep, and longitudinal risk of frailty in adults ages 65 and older.

13 Nov 2019

Alzheimer's Association awarded NIH grant for psychosocial dementia care research

The Alzheimer's Association announced that it has received a $1.34 million dollar grant from the National Institutes of Health to strengthen the current framework for psychosocial research examining care for people living with dementia and their care partners.

13 Nov 2019

Fluorescent carbon dots can effectively detect calcium levels in cells

In hospitals, doctors often advise patients to take calcium supplements. But does the calcium get into the cells that need it? Until recently, it's been hard to tell.

12 Nov 2019

Retinal hyperspectral imaging shows promise for early Alzheimer's disease detection

Alzheimer's disease is the leading cause of dementia in the U.S., with approximately 5.4 million currently affected and an estimated 16 million by 2050.

11 Nov 2019

Australia has limited capacity to move future Alzheimer's therapy into wide clinical use

As in other countries, the Australian health care system has limited capacity to rapidly move a future treatment for Alzheimer's disease from approval into wide clinical use, which could leave thousands of older people without access to transformative care if such a breakthrough occurs, according to a new study by RAND Australia.

11 Nov 2019

Compound that may help delay onset of Alzheimer’s can be produced in baker’s yeast

Scientists prove that ergothioneine, an important compound that may be used to delay the onset of diseases such as Alzheimer’s and dementia, can be produced in baker’s yeast.

11 Nov 2019

Medopad collaborates with Janssen to validate, commercialize novel automated cognitive tool

Medopad today announced a strategic collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to validate, scale and potentially commercialize the ReVeRe platform as a novel digital biomarker for Alzheimer's disease. This deal was facilitated by Johnson & Johnson Innovation Limited.

From J&J Innovative Medicine 11 Nov 2019

Regenstrief scientists will play key role in nationwide effort to improve care for dementia patients

Regenstrief research scientists Christopher Callahan, M.D., and Alexia Torke, M.D., will play a key role in a major nationwide effort to improve healthcare and quality of life for people with Alzheimer's disease and related dementias.

8 Nov 2019

Could improving the brain’s waste disposal system help prevent Parkinson’s and Alzheimer’s?

A new partnership between two leading medical research charities has launched today to explore how improving the brain’s waste disposal system could be the key to preventing Parkinson’s and Alzheimer’s disease.

8 Nov 2019

Alzheimer's Disease News and Research

Further Reading

Scientists discover new molecular drivers of Parkinson's disease

Researchers develop new technology to inhibit the development of Alzheimer's disease

High-fat maternal diet can cause life-long changes in the fetal brain

Study: Almost 10% of diverse Latino populations meet the criteria for mild cognitive impairment

Key Alzheimer's gene variants act differently among Caribbean Hispanics based on ancestry

Study: Many patients treated for iNPH also develop Alzheimer’s disease

Non-coding enhancer DNA may be key for identifying genetic risk in neurological conditions

Alzheimer's Association's funding enables expansion of aging study in longest running birth cohort

Good fitness linked to longer life without dementia

Alzheimer's Research UK urges all political parties to invest in dementia research

People who are illiterate may have greater risk of developing dementia

Regular co-use of pain and sleep medications may increase risk of frailty in older adults

Alzheimer's Association awarded NIH grant for psychosocial dementia care research

Fluorescent carbon dots can effectively detect calcium levels in cells

Retinal hyperspectral imaging shows promise for early Alzheimer's disease detection

Australia has limited capacity to move future Alzheimer's therapy into wide clinical use

Compound that may help delay onset of Alzheimer’s can be produced in baker’s yeast

Medopad collaborates with Janssen to validate, commercialize novel automated cognitive tool

Regenstrief scientists will play key role in nationwide effort to improve care for dementia patients

Could improving the brain’s waste disposal system help prevent Parkinson’s and Alzheimer’s?

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News